NJ AJR 161
in committeeEstablishes New Jersey Pancreatic Cancer Commission.
New Jersey · 222 · lower
Quick answers
Did NJ AJR 161 pass?
Not yet. NJ AJR 161 is in committee as of 2026-03-16 and has not come to a final vote. Latest recorded action (2026-03-16): Introduced, Referred to Assembly Health Committee
What is NJ AJR 161 about?
NJ AJR 161 is a joint resolution in the 222 titled “Establishes New Jersey Pancreatic Cancer Commission.”.
Who sponsors NJ AJR 161?
Speight, Shanique, Donlon, Margie, M.D. are the primary sponsors of NJ AJR 161.
- Introduced
- 2026-03-16
- Latest action
- 2026-03-16 — Introduced, Referred to Assembly Health Committee
- Bill type
- joint resolution
- Last updated
- —
Sponsors
- Speight, Shaniqueprimary
- Donlon, Margie, M.D.primary
Committees
Not provided by source.
Action timeline
2026-03-16
Introduced, Referred to Assembly Health Committee
introduction,referral-committee
Versions
- IntroducedCompare
Documents
Votes
Not provided by source.
Related bills
No related bills recorded for this bill.
Official source
Attribution
Data from openstates_api_sync, retrieved 2026-09-13T06:34:57.164819Z
Inspect retained evidence for changes recorded after evidence tracking began:
Use this data
Every field on this page is available from the free public API — no key or licence required. Fetch this bill as JSON: GET /api/v1/bills?jurisdiction=NJ&identifier=AJR 161. See the API docs or the MCP server for AI assistants.
Known limitations
- Sponsor party and chamber affiliation are not yet captured by this API.
- Committee referrals are not yet captured.
See the methodology page for data sources and limitations.